In vivo intratumoral administration of the SLN-STAT3 ODN-decoy into mice bearing SKOV3 tumors resulted in a significantly higher tumor growth inhibition compared with the treatment with non-specific scrambled ODN-decoy molecules. Here, STAT3 is linked to neoplasm.